GHK-Cu (Copper Peptide)
Get a source-linked, educational explanation from this profile.
Complete Research Guide
Open each section for the available evidence. Gaps are stated rather than inferred.
Overview
GHK-Cu (Copper Peptide) is listed as regenerative / skin.
- •Skin regeneration
- •Wound healing
- •Hair growth
- •Anti-aging
- •Antioxidant
Regulatory status: Not FDA-approved (injectable); cosmetic ingredient (topical).
Structure & Properties
Compound: GHK-Cu (Copper Peptide); also known as Copper Tripeptide-1.
Pharmacologic class: Regenerative / Skin.
Known delivery routes: Topical, Subcutaneous (off-label).
Sequence, molecular weight, salt form, and excipient details are formulation-specific and are not listed unless verified by a manufacturer or laboratory COA.
How It Works
Chelates copper ions → activates superoxide dismutase and metalloproteinases; upregulates collagen/elastin/GAG synthesis; modulates TGF-β; anti-inflammatory.
- •Improved skin firmness and clarity
- •Wound healing acceleration
- •Hair-follicle support
- •Antioxidant effects
Human Research
Evidence grade: Pre-clinical / Observational
Evidence is primarily preclinical or observational; human effectiveness and long-term safety are not established.
Laboratory Research
Extensive in vitro/animal; limited human topical RCTs
Preclinical findings describe biological plausibility, not proven benefit in people. Animal and laboratory doses do not translate directly to human use.
Processing & Interactions
Timing and exposure
Topical: apply to clean skin 1–2× daily (AM/PM). Injectable SubQ: once daily, timing flexible. Do not combine topical GHK-Cu with strong exfoliating acids or vitamin C in the same routine — the copper is destabilized.
Potential interactions and combinations to avoid
- •Same-application vitamin C, AHA/BHA, retinoids (topical) — separate by 12 hrs
- •Wilson's disease — copper contraindication
Absorption, half-life, metabolism, and clearance can vary by formulation and route. Use prescribing information when an approved product exists.
Safety & Precautions
Known or reported risks
- •Injectable human safety data is very limited
- •Theoretical excess-copper concerns
Contraindications
- •Wilson's disease
- •Copper hypersensitivity
- •Active malignancy (injectable, theoretical)
- •Broken, infected, sunburned, or actively inflamed skin
- •Concurrent prescription retinoid, chemical peel, or laser resurfacing without dermatologic guidance
- •Known copper sensitivity or Wilson's disease (copper-carrier peptides)
- •Eczema, rosacea, or perioral dermatitis in active flare
- •Bleeding disorders or anticoagulant therapy without physician guidance (injection-site haematoma)
- •Active skin infection, cellulitis, or lipohypertrophy at intended injection sites
- •Inability to maintain sterile technique or safe sharps disposal
- •Not FDA-approved for human therapeutic use — no verified purity, sterility, or potency standards
- •Immunocompromised or transplant patients (unverified sterility and immunogenicity risk)
- •Concurrent participation in drug-tested sport (WADA prohibited or non-cleared substance)
- •Known hypersensitivity or prior reaction to this compound or any excipient/diluent
- •Pregnancy, attempting conception, or breastfeeding unless prescribed and monitored by a physician
- •Children and adolescents with open growth plates (unless under specialist endocrine care)
- •Active or recently treated malignancy without oncology clearance
- •Use without a confirmed diagnosis, baseline labs, and licensed clinical supervision
Unknown long-term toxicity should be assumed where controlled human data are limited. Seek urgent care for a severe or unexpected reaction.
Administration & Studied Formulations
Reference range: Topical: 0.1–2%; Injectable: 1–5 mg (experimental)
Frequency: Daily (topical); variable (injectable)
Cycling: Topical: continuous. Injectable: 4–6 weeks on / 2 weeks off.
Topical
Skin, scar, and hair applications.
Serum (2–5%) or cream. Clean skin AM or PM. Never same-application with vitamin C, retinoids, or AHA/BHA — separate ≥12 hrs.
Subcutaneous
Systemic anti-aging / wound-healing protocols.
Insulin syringe. 1–3 mg SubQ near the target area. Solution may appear blue (copper) — normal.
Dosing information is educational context, not a personal recommendation. Approved products must follow their label and prescriber instructions.
Applications & Related Therapies
Potentially complementary measures
- •BPC-157 during wound/scar recovery
- •Matrixyl / Argireline in topical routines (apply at different times of day)
Clinical use should account for diagnosis, approved alternatives, nutrition, activity, sleep, rehabilitation, current medicines, and appropriate monitoring.
Cases, Considerations & Ethics
Decision framework: establish the clinical goal, confirm evidence quality and legal status, screen contraindications and interactions, compare approved alternatives, define monitoring and stopping criteria, and use shared decision-making with a licensed clinician.
Case evidence: individual reports cannot establish safety or effectiveness and should not outweigh controlled trials.
Ethics: informed consent should distinguish established care from experimental use, disclose uncertainty and cost, avoid overstated claims, and never substitute research products for medically necessary care.
What is GHK-Cu (Copper Peptide)?
In plain words
GHK-Cu is a small protein fragment that binds copper and is found in skin-care cosmetics. It affects enzymes and signals involved in making skin-supporting materials and reducing inflammation. Researchers study it for skin repair and wound healing, but evidence comes from laboratory, animal, or observational research rather than proof of benefit in people. The injectable form is not FDA-approved, human safety data are very limited, and excess copper is a possible concern.
Technical definition
GHK-Cu, also known as Copper Tripeptide-1, is a copper-binding tripeptide complex studied for skin regeneration and wound healing. It chelates copper ions, activates superoxide dismutase and metalloproteinases, increases collagen, elastin, and glycosaminoglycan synthesis, and modulates TGF-β signaling, with anti-inflammatory effects. Evidence is preclinical or observational; it is a topical cosmetic ingredient, but its injectable form is not FDA-approved and has very limited human safety data.
Function
Dosing
Recommended Time of Day
Topical: evening skincare routine. Injectable: morning.
See “Timing & Interactions” below for full fasted/fed circumstances, what to avoid combining, and what pairs well.
Administration & Technique
Injection & Application Sites
- Scalp (topical) — Part hair and apply directly to the scalp; do not rinse for 4+ hrs.
- Face / neck (topical) — Clean dry skin, AM and PM, before moisturizer.
- Abdomen — 2 in (5 cm) away from the navel, either side. Fastest, most consistent SubQ absorption.
- Flank / love handle — Lateral fat pad above the hip. Good rotation site when the abdomen is tender.
- Outer thigh — Upper outer quadrant, a hand-width below the hip. SubQ pinch at 45°.
Diagram is a general illustration, not a medical instruction. Rotate sites every injection, keep 1 in (2.5 cm) between recent sites, and avoid scars, moles, bruises and the navel area.
Cycling
Topical: continuous. Injectable: 4–6 weeks on / 2 weeks off.
Timing & Interactions
- ·Same-application vitamin C, AHA/BHA, retinoids (topical) — separate by 12 hrs
- ·Wilson's disease — copper contraindication
- ·BPC-157 during wound/scar recovery
- ·Matrixyl / Argireline in topical routines (apply at different times of day)
Storage & Reconstitution
Reconstitution Calculator
1 mL = 100 units on a standard U-100 insulin syringe. Draw to the nearest 0.5 unit and confirm dosing with a clinician before injection.
Your Notes
Sign in to save personal notes on GHK-Cu (Copper Peptide) and sync them to Vial Lab.
Benefits
- ·Improved skin firmness and clarity
- ·Wound healing acceleration
- ·Hair-follicle support
- ·Antioxidant effects
Risks
- ·Injectable human safety data is very limited
- ·Theoretical excess-copper concerns
Contraindications
- ·Wilson's disease
- ·Copper hypersensitivity
- ·Active malignancy (injectable, theoretical)
- ·Broken, infected, sunburned, or actively inflamed skin
- ·Concurrent prescription retinoid, chemical peel, or laser resurfacing without dermatologic guidance
- ·Known copper sensitivity or Wilson's disease (copper-carrier peptides)
- ·Eczema, rosacea, or perioral dermatitis in active flare
- ·Bleeding disorders or anticoagulant therapy without physician guidance (injection-site haematoma)
- ·Active skin infection, cellulitis, or lipohypertrophy at intended injection sites
- ·Inability to maintain sterile technique or safe sharps disposal
- ·Not FDA-approved for human therapeutic use — no verified purity, sterility, or potency standards
- ·Immunocompromised or transplant patients (unverified sterility and immunogenicity risk)
- ·Concurrent participation in drug-tested sport (WADA prohibited or non-cleared substance)
- ·Known hypersensitivity or prior reaction to this compound or any excipient/diluent
- ·Pregnancy, attempting conception, or breastfeeding unless prescribed and monitored by a physician
- ·Children and adolescents with open growth plates (unless under specialist endocrine care)
- ·Active or recently treated malignancy without oncology clearance
- ·Use without a confirmed diagnosis, baseline labs, and licensed clinical supervision
Regulatory
Not FDA-approved (injectable); cosmetic ingredient (topical)
Veterinary Use (Pets)
Topical and injectable use for wound healing, hair coat, and skin repair in small animals.